Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 6.04M P/E - EPS this Y 44.40% Ern Qtrly Grth -
Income -16.08M Forward P/E -0.40 EPS next Y 1.60% 50D Avg Chg -49.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -56.00%
Dividend N/A Price/Book 0.66 EPS next 5Y - 52W High Chg -82.00%
Recommedations 2.00 Quick Ratio 0.55 Shares Outstanding 1.57M 52W Low Chg 12.00%
Insider Own 0.11% ROA -103.19% Shares Float 677.85K Beta 0.38
Inst Own 1.80% ROE -220.02% Shares Shorted/Prior 27.37K/63.35K Price 0.76
Gross Margin - Profit Margin - Avg. Volume 132,850 Target Price 40.00
Oper. Margin - Earnings Date May 10 Volume 997,978 Change -22.53%
About Bio-Path Holdings, Inc.

Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. It is also developing BP1001-A that is in Phase I clinical trial for the treatment of solid tumors; Liposomal Bcl-2 (BP1002), which is in Phase I clinical trial for the treatment of refractory/relapsed lymphoma and chronic lymphocytic leukemia; and Liposomal STAT3 (BP1003) for treating pancreatic cancer, non-small cell lung cancer, and AML. The company was founded in 2007 and is based in Bellaire, Texas.

Bio-Path Holdings, Inc. News
04/19/24 Bio-Path Holdings, Inc. Announces Closing of $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
04/19/24 Bio-Path (BPTH) Rises on Upbeat Updates From Blood Cancer Study
04/18/24 Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
04/18/24 Bio-Path Holdings Announces Successful Completion of Higher Dose Second Cohort in Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia (AML) Patients
04/15/24 Bio-Path Holdings Expands Global Patent Portfolio
04/02/24 Bio-Path Holdings Provides 2024 Clinical and Operational Update
03/27/24 Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q4 23
03/10/24 Bio-Path Holdings, Inc. (NASDAQ:BPTH) Q4 2023 Earnings Call Transcript
03/08/24 Q4 2023 Bio Path Holdings Inc Earnings Call
03/08/24 Bio-Path Holdings Reports Full Year 2023 Financial Results
07:00 AM Bio-Path Holdings to Announce Fourth Quarter and Full Year 2023 Financial Results on March 8, 2024
02/21/24 Bio-Path Holdings Announces 1-for-20 Reverse Stock Split
02/17/24 When Can We Expect A Profit From Bio-Path Holdings, Inc. (NASDAQ:BPTH)?
01/10/24 Bio-Path Holdings Announces Completion of First Dose Cohort in Phase 1 Clinical Trial Evaluating BP1002 to Treat Refractory/Relapsed Lymphoma and Refractory/Relapsed Chronic Lymphocytic Leukemia Patients
12/14/23 Bio-Path Holdings Successfully Completes First Dose Cohort of Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia
11/20/23 Bio-Path Holdings, Inc. (NASDAQ:BPTH) Q3 2023 Earnings Call Transcript
11/15/23 Bio-Path Holdings Reports Third Quarter 2023 Financial Results
11/08/23 Bio-Path Holdings to Announce Third Quarter 2023 Financial Results on November 15, 2023
10/24/23 Bio-Path Holdings to Host Virtual Key Opinion Leader Event to Discuss Prexigebersen and Advances in the Treatment Landscape for Acute Myeloid Leukemia
09/10/23 Bio-Path Holdings, Inc.'s (NASDAQ:BPTH) Profit Outlook
BPTH Chatroom

User Image starforce33 Posted - 3 hours ago

$BPTH what kind of things or trials we got on radar here looking like a possible run to 20

User Image GreenReaperx Posted - 6 hours ago

$BPTH What the hell is wrong here????! Why is the volume so shitty??

User Image DayWinger Posted - 7 hours ago

$BPTH more information on protecting your shares from being loaned out for short selling. If you have a margin account, you have in essence agreed to allow your broker to loan out your shares for short selling. Consequently, you need to either move your shares into a cash account with instructions not to loan your shares out for short selling, or convert your margin account back to a cash account. Converting your account takes more time. Either way, you need to tell the broker not to loan your shares for short selling. Allowing them to loan your shares is giving them permission to use your money against you!

User Image Bionix Posted - 8 hours ago

$BPTH Very small float + Phs2 3rd cohort data = FDA Fast Track or Breakthrough filing πŸš€

User Image DeezNuttz Posted - 04/30/24

$BPTH

User Image Fast_Eddie_Felson Posted - 04/30/24

$BPTH garbage shithole. Scumbag management.

User Image DeezNuttz Posted - 04/30/24

$BPTH

User Image naseem1 Posted - 04/30/24

$HOLO POS! real stocks, $AGBA. $BPTH, $MULN and many more....!

User Image DeezNuttz Posted - 04/30/24

$BPTH Love shorting this nasty pig scam πŸ€£πŸ˜‚πŸ€£πŸ˜‚πŸ€£πŸ˜‚

User Image DayWinger Posted - 04/29/24

$BPTH we've done a fairly good job of tying up a lot of lose ends. We can start paying a little more attention to price and volume now. However, this is no time to get sloppy. Every new share you purchase make sure your broker knows that it is not to be loaned out for short selling.. Also, BPTH needs to still cleanup their lose ends. Continue to email Doug Morris. He needs to put his unissued and restricted shares in a cash account or somewhere that these short sellers can't get to them. The bears have had far too much access to shares that should have never been loaned to them!

User Image RollingDollar Posted - 04/29/24

$BPTH

User Image GreenReaperx Posted - 04/29/24

$BPTH We are up even with this shitty volume!! Imagine if we are at 4-5 Million in volume!! Then we’ll be at $5-$7 per share!!! LFG!!!!!

User Image billabongh2o Posted - 04/29/24

$BPTH $APVO another bio bought out DCPH

User Image RollingDollar Posted - 04/29/24

$BPTH

User Image DeezNuttz Posted - 04/29/24

$BPTH

User Image GreenReaperx Posted - 04/29/24

$BPTH Wow, the volume is really shitty !! Ughhh

User Image DayWinger Posted - 04/29/24

$BPTH if you're long, please take a moment to email Doug Morris at BPTH, [email protected] . Tell him to ensure the shares in reserve and restricted are protected from short selling. BPTH needs to make sure those shares are not available for loans to short sellers. Likewise, make sure your shares are not available to short sellers. Simply message your broker and tell him that your shares are not to be loaned out for short selling. My heck, they should have at least been paying us if they loaned out our shares. What a rip off.

User Image the_grinch71 Posted - 04/29/24

$IBRX i can remember another one that is very similar who run big in tha past.... $BPTH

User Image DeezNuttz Posted - 04/29/24

$BPTH

User Image Stocksrunner Posted - 04/27/24

πŸ“Š Companies Under the Lens! πŸ” Monitoring & Ratings: $DCBO Strong Buy sentiment πŸ“ˆ $BPTH Rated as Buy πŸ’Ό $MNSB Holding steady with a Hold sentiment 🀝 Keep tabs on these stocks for potential opportunities!

User Image Bad_The_Bull_Bunny Posted - 04/26/24

$BPTH looks like it found bottom so took some for a swing Gl bulls

User Image DeezNuttz Posted - 04/26/24

$BPTH

User Image DayWinger Posted - 04/26/24

$BPTH it is very imprtant that we get BPTH to cut off any ability to loan out their shares as well as institutional investors from loaning out their shares for short sells. Email D Morris at BPTH and make sure he gets access to BPTH and Institutional investors shut down from short selling shares owned by

User Image GreenReaperx Posted - 04/26/24

$BPTH Reversal in action!!! I hope to see $4++ next week!!! πŸ€‘πŸ€‘

User Image gstock568 Posted - 04/26/24

$EJH Sorry Longs. This is a β€œtotal” POS. Worse than $MULN and $BPTH

User Image DayWinger Posted - 04/26/24

$BPTH good job of closing down access. Now we need to put some pressure on BPTH Mgt. email D Morris, email address is on the BPTH web site. Tell him to ensure access is cut off to their shares and that they are contacting their institutional investors to shut down access to their shares also. If they receive enough pressure from us, they'll get it done! Don't let the price distract you. Let's get the dynamics in our favor

User Image RollingDollar Posted - 04/26/24

$BPTH .

User Image DayWinger Posted - 04/26/24

$BPTH before worrying about price increases, let's get the dynamics right. The bears have had far too much access to your shares. We need to continue to call our brokers and tell them your shares are NOT to be lent out for short selling. Some brokers have requested a letter. If they do send them one that says my shares are not to be loaned out for short selling. Jeeze, if they are going to lend out our shares, they should have been paying us interest or rent or something πŸ€”

User Image DeezNuttz Posted - 04/26/24

$BPTH

User Image Allen_trn Posted - 04/26/24

$BPTH

Analyst Ratings
Roth MKM Buy Apr 18, 24
Roth MKM Buy Mar 27, 24